Real-world outcomes associated with initial oral CGRP receptor antagonist integration strategies in children and adolescents with migraine: a multicenter cohort study
This multicenter cohort study of 109 children and adolescents with migraine found that adding rimegepant to conventional preventive therapy was associated with numerically higher response rates for reducing monthly headache days compared to conventional therapy alone, particularly for achieving a ≥75% reduction, though the primary outcomes did not reach statistical significance, suggesting a need for further prospective evaluation.